First Merchants Corp Bristol Myers Squibb CO Transaction History

First Merchants Corp

$1.42 Billion
Q3 2024

A detailed history of First Merchants Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Merchants Corp holds 31,052 shares of BMY stock, worth $1.79 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

31,052

Previous 31,167 0.37%

Holding current value

$1.79 Million

Previous $1.29 Million 24.11%

% of portfolio

0.11%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $4,560 - $5,951	-115 Reduced 0.37%	31,052 $1.61 Million
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $1.09 Million - $1.43 Million	27,010 Added 649.75%	31,167 $1.29 Million
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $815 - $924	17 Added 0.41%	4,157 $225,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $104,665 - $117,031	-1,808 Reduced 30.4%	4,140 $240,000
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $14,334 - $15,916	-225 Reduced 3.64%	5,948 $380,000
Q1 2023 Apr 25, 2023	SELL	$65.71 - $74.53 $17,675 - $20,048	-269 Reduced 4.18%	6,173 $427,000
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $95,872 - $113,526	1,400 Added 27.77%	6,442 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $101 - $59,704	777 Added 18.22%	5,042 $358,000
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $19,970 - $21,994	-275 Reduced 6.06%	4,265 $328,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $8,422 - $10,099	-137 Reduced 2.93%	4,540 $332,000
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $38,613 - $45,014	-720 Reduced 13.34%	4,677 $292,000
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $48,519 - $56,834	820 Added 17.92%	5,397 $319,000
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $1.65 Million - $1.8 Million	-26,689 Reduced 85.36%	4,577 $306,000
Q1 2021 Apr 22, 2021	BUY	$59.34 - $66.74 $1.86 Million - $2.09 Million	31,266 New	31,266 $1.97 Million
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $213,325 - $276,631	-4,375 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $126,325 - $157,450	-2,500 Reduced 36.36%	4,375 $242,000
Q1 2018 Apr 26, 2018	BUY	$59.92 - $68.98 $4,793 - $5,518	80 Added 1.18%	6,875 $435,000
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $46,453 - $50,646	-775 Reduced 10.24%	6,795 $417,000
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $418,091 - $482,511	7,570	7,570 $482,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Account

First Merchants Corp Bristol Myers Squibb CO Transaction History